Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma

NCT06916416 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT06916416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06916416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma
Lead sponsor
University of Cologne
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 30, 2025
Completion date
June 30, 2028
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

classical hodgkin lymphoma